Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Gershkowitz Jayne
Relationship:   SVP, Chief Patient Adv...
City:   Cranbury
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   5,693    

Indirect Shares

  0      
Direct Value   $60,403    

Indirect Value

  $0      
Total Shares   5,693      
Total Value   $60,403      


Amicus Therapeutics Inc
 $60,403 Amicus Therapeutics Inc
 $60,403
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Amicus Therapeutics Inc FOLD SVP, Chief Patient Adv... 2015-07-01 5,693 2014-04-10 0    Premium*  
* Premium Members only  

Records found :    14         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
FOLD Amicus Therapeutics Inc SVP, Chief Patient Advocate   •       –      –    2015-07-01 4 AS $13.97 $148,818 D/D (10,649) 5,693 0 -
FOLD Amicus Therapeutics Inc SVP, Chief Patient Advocate   •       –      –    2015-07-01 4 OE $13.97 $148,818 D/D 10,649 16,342 0 -
FOLD Amicus Therapeutics Inc SVP, Chief Patient Advocate   •       –      –    2015-05-11 4 AS $10.84 $108,389 D/D (10,000) 5,693 0 -
FOLD Amicus Therapeutics Inc SVP, Chief Patient Advocate   •       –      –    2015-05-08 4 D $10.80 $100,516 D/D (9,307) 15,693 0 -
FOLD Amicus Therapeutics Inc SVP, Chief Patient Advocate   •       –      –    2015-05-08 4 OE $0.00 $0 D/D 25,000 25,000 0 -
FOLD Amicus Therapeutics Inc VP, Patient Advocacy   •       –      –    2015-03-20 4 AS $11.51 $122,568 D/D (10,648) 50,000 0 -
FOLD Amicus Therapeutics Inc VP, Patient Advocacy   •       –      –    2015-03-20 4 OE $11.51 $122,568 D/D 10,648 60,648 0 -
FOLD Amicus Therapeutics Inc VP, Patient Advocacy   •       –      –    2014-08-27 4 AS $7.00 $35,000 D/D (5,000) 50,000 0 -
FOLD Amicus Therapeutics Inc VP, Patient Advocacy   •       –      –    2014-08-27 4 AB $7.00 $35,000 D/D 5,000 55,000 0 -
FOLD Amicus Therapeutics Inc VP, Patient Advocacy   •       –      –    2014-08-25 4 AS $6.00 $30,000 D/D (5,000) 50,000 0 -
FOLD Amicus Therapeutics Inc VP, Patient Advocacy   •       –      –    2014-08-25 4 AB $6.00 $30,000 D/D 5,000 55,000 0 -
FOLD Amicus Therapeutics Inc VP, Patient Advocacy   •       –      –    2014-08-20 4 AS $5.40 $32,832 D/D (6,080) 50,000 0 -
FOLD Amicus Therapeutics Inc VP, Patient Advocacy   •       –      –    2014-08-20 4 AB $5.40 $32,832 D/D 6,080 56,080 0 -
FOLD Amicus Therapeutics Inc VP, Patient Advocacy   •       –      –    2014-04-10 4 A $0.00 $0 D/D 50,000 50,000 0 -

  14  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed